Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Stuart Orkin, John Burn, Clint Winter, Terry Lively, More

Premium

The American Society of Human Genetics has named Stuart Orkin as recipient of the annual William Allan Award for his research into the genetics of blood diseases. Orkin is a professor of pediatrics at Harvard Medical School, chairman of the department of pediatric oncology at Dana-Farber Cancer Institute, associate chief of hematology and oncology at Boston Children's Hospital, and investigator of the Howard Hughes Medical Institute at Boston Children's Hospital.


The UK's National Health Service has appointed John Burn to its board of directors as a non-executive director for four years beginning July 1. Burn is the chief medical officer of QuantuMDx and holds the NHS Endowed Chair in Clinical Genetics at Newcastle University.


CompanionDx Reference Lab has expanded its leadership team. The firm has hired Clint Winter as vice president of payer strategy and managed care. Terry Lively will join as vice president of new business development, where he will focus on next-generation sequencing commercialization. Ronald Conheim will serve as vice president of sales for the eastern US; Roderick Booker will be vice president of sales for the central US; and Roger Saadeh will be vice president of sales for the western US. Stacey Little has been tapped to lead strategic marketing, marketing communications, and brand management for the US and international markets as vice president of marketing and communications.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.